Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval_老虎社区_美港股上老虎

Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval

The Wall Street Journal2021-06-24

(Update: June 24, 2021 at 09:32 a.m. ET)

Eli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.

The move is meant to expedite the development and review of the experimental treatment.

Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

Mml
·2021-06-27
Informative
回复
点赞
举报
Lamborghini1
·2021-06-27
Yeah
回复
1
举报
evey77
·2021-06-27
Good news for patients!
回复
2
举报
小霖妹子
·2021-06-26
Cool
回复
1
举报
Kenny1911
·2021-06-26
Cool👍
回复
1
举报
Mml
·2021-06-25
Great
回复
1
举报
黑黑贝尔
·2021-06-25
Gonna get this today :)
回复
2
举报
收起
- 6ecbefc2:
  Great
  2021-06-26
  回复
  举报
奔雷钞票
·2021-06-25
Wow sounds good
回复
2
举报
HODLING
·2021-06-25
Yes
回复
2
举报
Fredteh
·2021-06-25
Good news for Lily but bad news for Biogen
回复
6
举报
收起
- Crappybara:
  Yes
  2021-06-25
  回复
  举报
- 小霖妹子:
  Yea
  2021-06-26
  回复
  举报
Gaga71
·2021-06-25
Different market sentiment
回复
3
举报
我i168
·2021-06-25
👍
回复
1
举报
Phyusin
·2021-06-24
Wow
回复
点赞
举报
Hahaalibaba
·2021-06-24
Good read
回复
点赞
举报
1000010101O
·2021-06-24
[Smile] [Miser]
回复
点赞
举报
Orangejus
·2021-06-24
Damn… should have held =p
回复
1
举报
wowgood
·2021-06-24
Wow interesting
回复
2
举报
BOCHARP
·2021-06-24
Like and share
回复
1
举报
Lammie
·2021-06-24
[Smile]
回复
1
举报
VinKuang
·2021-06-24
Like and comment tyvm
回复
4
举报
收起
- mich89:
  Done!
  2021-06-24
  回复
  举报
- Christyne:
  Nice
  2021-06-24
  回复
  举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1113369372?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-06-24 19:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113369372","market":"us","top_or_hot":-1,"title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","media":"The Wall Street Journal","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LLY","symbol_name":"礼来","start_time":0,"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","article_id":"1113369372","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","pubTimestamp":1624535308,"columns":[],"sourceInfo":null,"weMediaInfo":null,"summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","collect":0,"end_time":0,"defaultTopTitle":"wsj.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LLY":"礼来"},"translate_title":"礼来公司股价上涨，生物原下降对阿尔茨海默氏症治疗的批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LLY":0.9},"content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[{"id":124550982,"gmtCreate":1624774011446,"gmtModify":1633948730888,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"htmlText":"Informative&nbsp;","listText":"Informative&nbsp;","text":"Informative","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/124550982","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":124379905,"gmtCreate":1624749993407,"gmtModify":1633949185156,"author":{"id":"3578903100181699","authorId":"3578903100181699","name":"Lamborghini1","avatar":"https://static.tigerbbs.com/f8b24a649554234324e1e33be42fc25f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3578903100181699","authorIdStr":"3578903100181699"},"htmlText":"Yeah","listText":"Yeah","text":"Yeah","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/124379905","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":124949668,"gmtCreate":1624723430954,"gmtModify":1631890322333,"author":{"id":"3570619054429964","authorId":"3570619054429964","name":"evey77","avatar":"https://static.tigerbbs.com/8a042e238635d0f206ea5cc76045eb40","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"3570619054429964","authorIdStr":"3570619054429964"},"htmlText":"Good news for patients!","listText":"Good news for patients!","text":"Good news for patients!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/124949668","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":125572127,"gmtCreate":1624682835069,"gmtModify":1633949606069,"author":{"id":"3579326417741698","authorId":"3579326417741698","name":"小霖妹子","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579326417741698","authorIdStr":"3579326417741698"},"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125572127","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":125940203,"gmtCreate":1624643707202,"gmtModify":1633950118014,"author":{"id":"3585379063279167","authorId":"3585379063279167","name":"Kenny1911","avatar":"https://static.tigerbbs.com/103f35c8c97a332b73a2ac784f165e23","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3585379063279167","authorIdStr":"3585379063279167"},"htmlText":"Cool👍","listText":"Cool👍","text":"Cool👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/125940203","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122464605,"gmtCreate":1624630546007,"gmtModify":1633950300533,"author":{"id":"3584863771682470","authorId":"3584863771682470","name":"Mml","avatar":"https://static.tigerbbs.com/f24c9f80edf3964f1c5ee7b551e05463","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3584863771682470","authorIdStr":"3584863771682470"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122464605","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":122690842,"gmtCreate":1624614780086,"gmtModify":1631888952203,"author":{"id":"3578209778948830","authorId":"3578209778948830","name":"黑黑贝尔","avatar":"https://static.tigerbbs.com/d85f841902a6d6d1ff30d90ef59b9d5a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3578209778948830","authorIdStr":"3578209778948830"},"htmlText":"Gonna get this today :)","listText":"Gonna get this today :)","text":"Gonna get this today :)","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/122690842","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5024677,"gmtCreate":1624676033154,"gmtModify":1631888952200,"authorId":3571972721443950,"author":{"id":3571972721443950,"idStr":"3571972721443950","authorId":3571972721443950,"name":"6ecbefc2","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":122690842,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"EN"},{"id":122078444,"gmtCreate":1624590415888,"gmtModify":1633950817013,"author":{"id":"3573117142777497","authorId":"3573117142777497","name":"奔雷钞票","avatar":"https://static.tigerbbs.com/2c3d6fd1582e91af287ad0fd9636b62b","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3573117142777497","authorIdStr":"3573117142777497"},"htmlText":"Wow sounds good","listText":"Wow sounds good","text":"Wow sounds good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/122078444","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126477162,"gmtCreate":1624583416856,"gmtModify":1631889801685,"author":{"id":"3586773315020576","authorId":"3586773315020576","name":"HODLING","avatar":"https://static.tigerbbs.com/ba0e78d9668dfff03e39bc811f9fa61f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3586773315020576","authorIdStr":"3586773315020576"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126477162","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126557282,"gmtCreate":1624579757046,"gmtModify":1631889380242,"author":{"id":"3560929247961996","authorId":"3560929247961996","name":"Fredteh","avatar":"https://static.tigerbbs.com/61eaccb8085fb08c692502d98314f43d","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3560929247961996","authorIdStr":"3560929247961996"},"htmlText":"Good news for Lily but bad news for Biogen","listText":"Good news for Lily but bad news for Biogen","text":"Good news for Lily but bad news for Biogen","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/126557282","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5004039,"gmtCreate":1624580201986,"gmtModify":1635247610477,"authorId":3581494316592228,"author":{"id":3581494316592228,"idStr":"3581494316592228","authorId":3581494316592228,"name":"Crappybara","avatar":"https://static.tigerbbs.com/0a085697d49b443650c5a80b0fa9a50f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":126557282,"type":1,"supId":0,"prevId":0,"content":"Yes","text":"Yes","html":"Yes"},{"id":5026115,"gmtCreate":1624682859920,"gmtModify":1635245689903,"authorId":3579326417741698,"author":{"id":3579326417741698,"idStr":"3579326417741698","authorId":3579326417741698,"name":"小霖妹子","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":126557282,"type":1,"supId":0,"prevId":0,"content":"Yea","text":"Yea","html":"Yea"}],"langContent":"EN"},{"id":126265071,"gmtCreate":1624576079393,"gmtModify":1634004281324,"author":{"id":"3579082097230100","authorId":"3579082097230100","name":"Gaga71","avatar":"https://static.tigerbbs.com/02afa88b95dc30f4a60767c18f9e2f39","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3579082097230100","authorIdStr":"3579082097230100"},"htmlText":"Different market sentiment&nbsp;","listText":"Different market sentiment&nbsp;","text":"Different market sentiment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126265071","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126203445,"gmtCreate":1624572491387,"gmtModify":1624572491387,"author":{"id":"3563873670221480","authorId":"3563873670221480","name":"我i168","avatar":"https://static.tigerbbs.com/34b2d0551b5ab028c13ab35747c4df8c","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3563873670221480","authorIdStr":"3563873670221480"},"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126203445","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126167224,"gmtCreate":1624548083268,"gmtModify":1634004507321,"author":{"id":"3584490239949882","authorId":"3584490239949882","name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3584490239949882","authorIdStr":"3584490239949882"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126167224","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126921699,"gmtCreate":1624542644711,"gmtModify":1631891373028,"author":{"id":"3582001007986071","authorId":"3582001007986071","name":"Hahaalibaba","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3582001007986071","authorIdStr":"3582001007986071"},"htmlText":"Good read&nbsp;","listText":"Good read&nbsp;","text":"Good read","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126921699","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126055197,"gmtCreate":1624539333419,"gmtModify":1634004709150,"author":{"id":"3581326346667529","authorId":"3581326346667529","name":"1000010101O","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3581326346667529","authorIdStr":"3581326346667529"},"htmlText":"[Smile]&nbsp;[Miser]&nbsp;","listText":"[Smile]&nbsp;[Miser]&nbsp;","text":"[Smile] [Miser]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126055197","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126088272,"gmtCreate":1624537621496,"gmtModify":1634004734284,"author":{"id":"3586565070413371","authorId":"3586565070413371","name":"Orangejus","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3586565070413371","authorIdStr":"3586565070413371"},"htmlText":"Damn… should have held =p&nbsp;","listText":"Damn… should have held =p&nbsp;","text":"Damn… should have held =p","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126088272","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126014984,"gmtCreate":1624537343848,"gmtModify":1634004739125,"author":{"id":"3581759439509826","authorId":"3581759439509826","name":"wowgood","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581759439509826","authorIdStr":"3581759439509826"},"htmlText":"Wow interesting","listText":"Wow interesting","text":"Wow interesting","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126014984","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126012099,"gmtCreate":1624537264111,"gmtModify":1634004740272,"author":{"id":"3576492761186891","authorId":"3576492761186891","name":"BOCHARP","avatar":"https://static.tigerbbs.com/aa29f3c7da56608b062745f4f54f8524","vip":1,"crmLevel":8,"crmLevelSwitch":0,"idStr":"3576492761186891","authorIdStr":"3576492761186891"},"htmlText":"Like and share&nbsp;","listText":"Like and share&nbsp;","text":"Like and share","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126012099","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126011346,"gmtCreate":1624537117185,"gmtModify":1634004742954,"author":{"id":"3579863048316157","authorId":"3579863048316157","name":"Lammie","avatar":"https://static.tigerbbs.com/22f853e264a96287b9819a7a9d2d2f84","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579863048316157","authorIdStr":"3579863048316157"},"htmlText":"[Smile]&nbsp;","listText":"[Smile]&nbsp;","text":"[Smile]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/126011346","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":126011050,"gmtCreate":1624537106170,"gmtModify":1634004743078,"author":{"id":"3577323914202336","authorId":"3577323914202336","name":"VinKuang","avatar":"https://static.tigerbbs.com/536d624e5750dcffec704eeed9bc003b","vip":1,"crmLevel":7,"crmLevelSwitch":0,"idStr":"3577323914202336","authorIdStr":"3577323914202336"},"htmlText":"Like and comment tyvm","listText":"Like and comment tyvm","text":"Like and comment tyvm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/126011050","repostId":1113369372,"repostType":4,"repost":{"id":"1113369372","kind":"news","pubTimestamp":1624535308,"share":"https://www.laohu8.com/m/news/1113369372?lang=&edition=full","pubTime":"2021-06-24 19:48","market":"us","language":"en","title":"Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1113369372","media":"The Wall Street Journal","summary":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after th","content":"<p><i><b>(Update: June 24, 2021 at 09:32 a.m. ET)</b></i></p>\n<p>Eli Lilly shares jumped over 8% in&nbsp;morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.</p>\n<p><img src=\"https://static.tigerbbs.com/9b4cea69bed4d928fd18195924788827\" tg-width=\"658\" tg-height=\"438\"></p>\n<p>The move is meant to expedite the development and review of the experimental treatment.</p>\n<p>Rival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Eli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEli Lilly Stock Jumps, Biogen Drops on Alzheimer's Treatment Approval\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 19:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from ...</p>\n\n<a href=\"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LLY":"礼来"},"source_url":"https://www.wsj.com/livecoverage/stock-market-news-live-updates-062421/card/C1AeSf1mE5Wh1f1ra8mc","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1113369372","content_text":"(Update: June 24, 2021 at 09:32 a.m. ET)\nEli Lilly shares jumped over 8% in morning trading after the drug maker said it received breakthrough therapy designation for its Alzheimer's treatment from the Food and Drug Administration.\n\nThe move is meant to expedite the development and review of the experimental treatment.\nRival Biogen, whose own drug was approved earlier this month, fell over 6% in premarket trading. The FDA has faced criticism from some doctors and scientists for approving that drug.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4995642,"gmtCreate":1624537747855,"gmtModify":1635248370039,"authorId":3562879402794963,"author":{"id":3562879402794963,"idStr":"3562879402794963","authorId":3562879402794963,"name":"mich89","avatar":"https://static.tigerbbs.com/986536261ba69d3973d078ff6a5abe13","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":126011050,"type":1,"supId":0,"prevId":0,"content":"Done!","text":"Done!","html":"Done!"},{"id":4995950,"gmtCreate":1624539055626,"gmtModify":1635248343050,"authorId":3581556079916824,"author":{"id":3581556079916824,"idStr":"3581556079916824","authorId":3581556079916824,"name":"Christyne","avatar":"https://static.tigerbbs.com/0992968866edbb36b61df9f9a1d29da9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":126011050,"type":1,"supId":4995642,"prevId":0,"content":"Nice","text":"Nice","html":"Nice"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":96,"commentSize":25,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}